FIELD: medicine.
SUBSTANCE: present invention refers to medicine. Disclosed is a method for assessing the risk of disease in a user based on genetic data and data on the composition of intestinal microbiota, as well as the occurrence of the disease, genetic and external risk factors.
EFFECT: present invention provides higher accuracy of assessing the risk of disease in a user.
7 cl, 7 dwg, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| SYSTEM AND METHOD OF INTERPRETING DATA AND PROVIDING RECOMMENDATIONS TO USER BASED ON GENETIC DATA THEREOF AND DATA ON COMPOSITION OF INTESTINAL MICROBIOTA | 2017 |
|
RU2699284C2 |
| METHOD AND SYSTEM FOR TRACKING A RATION AND FORMING AN OPINION ON THE QUALITY OF NUTRITION AND / OR INDIVIDUAL NUTRITION RECOMMENDATIONS | 2019 |
|
RU2721234C1 |
| METHOD AND SYSTEM FOR INDIVIDUAL FOOD RATION FORMATION AFTER MICROBIOTA TRANSPLANTATION | 2018 |
|
RU2699283C1 |
| METHOD FOR DETERMINATION OF INDIVIDUAL GENETIC RISK FOR ISCHEMIC STROKE | 2014 |
|
RU2612630C2 |
| METHOD FOR DETERMINING PRESENCE OR ABSENCE OF AGGRESSIVE PROSTATE CANCER | 2013 |
|
RU2675370C2 |
| PROGNOSTIC METHOD FOR INDIVIDUALS WITH PROSTATE CANCER | 2013 |
|
RU2669809C2 |
| KIT FOR PREDICTION OR DIAGNOSTICS OF NON-ALCOHOLIC FATTY LIVER DISEASE AND A METHOD OF DIAGNOSTICS OF NON-ALCOHOLIC FATTY LIVER DISEASE | 2020 |
|
RU2800086C1 |
| RISK MARKERS FOR CARDIOVASCULAR DISEASES IN PATIENTS WITH CHRONIC KIDNEY DISEASE | 2014 |
|
RU2656148C2 |
| MARKERS OF RISK OF CARDIOVASCULAR DISEASE | 2010 |
|
RU2524659C2 |
| METHOD OF DIAGNOSING LUPUS IN HUMAN | 2010 |
|
RU2596391C2 |
